secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001493152-24-025289
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem amends Series F-1 Preferred; conversion price set at $0.0154, adjustment provisions removed
--------------------------------------------------------------------------------

- Amended Certificate of Designation removes Section 8(h) adjustment provisions from Series F-1 Preferred.
- Conversion Price changed to $0.0154 per share; previously subject to adjustment.
- Approved by unanimous written consent of Required Holders.
- Filed with Delaware Secretary of State on June 20, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224025289/0001493152-24-025289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224025289/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer